Wallstreet.K
2024-02-16
Great ariticle, would you like to share it?
@港澳IPO上市：
63家“未盈利生物科技公司”2023年终盘点
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":274642158862456,"tweetId":"274642158862456","gmtCreate":1708089165644,"gmtModify":1708089167088,"author":{"id":3500238355015318,"idStr":"3500238355015318","authorId":3500238355015318,"authorIdStr":"3500238355015318","name":"Wallstreet.K","avatar":"https://static.tigerbbs.com/61d094c7a0547adf0b9c40cc08143f0b","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.03","individualDisplayEnabled":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","name":"偶像虎友","description":"加入老虎社区1500天","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p>Great ariticle, would you like to share it?</p></body></html>","htmlText":"<html><head></head><body><p>Great ariticle, would you like to share it?</p></body></html>","text":"Great ariticle, would you like to share it?","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/274642158862456","repostId":270870461894664,"repostType":1,"repost":{"magic":2,"id":270870461894664,"tweetId":"270870461894664","gmtCreate":1707153085559,"gmtModify":1707153868916,"author":{"id":9000000000000028,"idStr":"9000000000000028","authorId":9000000000000028,"authorIdStr":"9000000000000028","name":"港澳IPO上市","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":8,"userType":8,"introduction":"-","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":271,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/ce841bc8a2f24d7abb80a7da31579c08"},{"img":"https://static.tigerbbs.com/f90093148eef4e948ac59921d1c98fa7"},{"img":"https://static.tigerbbs.com/2956d70fd0d94e1c91622c59924cabf6"},{"img":"https://static.tigerbbs.com/5d042843962249058415f6fa8101e53d"},{"img":"https://static.tigerbbs.com/398a7d4a9313486b8c3ee5d02763d2d9"},{"img":"https://static.tigerbbs.com/35a1f7cc2afc44b9a042eeaf7782203d"},{"img":"https://static.tigerbbs.com/9395ded9735b4a668233796053858155"}],"coverImages":[{"img":"https://static.tigerbbs.com/ce841bc8a2f24d7abb80a7da31579c08"},{"img":"https://static.tigerbbs.com/f90093148eef4e948ac59921d1c98fa7"},{"img":"https://static.tigerbbs.com/2956d70fd0d94e1c91622c59924cabf6"}],"title":"63家“未盈利生物科技公司”2023年终盘点","html":"<html><head></head><body><div>\n <p><span><img src=\"https://static.tigerbbs.com/ce841bc8a2f24d7abb80a7da31579c08\"></span></p>\n <p><span><span>截止至2023年12月31日，香港市场</span>共有<strong>63</strong>家未盈利生物科技公司在香港挂牌上市。</span><span><span>这<strong>63</strong>家全部在主板上市，从数量上来看，这<strong>63</strong>家占香港主板上市公司</span><strong><span>2,283</span></strong><span>家</span><span>的</span><span>2.76%；从市值上来看，这63家合计市值达<strong>5784.64</strong><strong>亿</strong>元<span>(港元，以下同)</span>，<span>较2022年12月31日未盈利生物科技公司总市值减少1388.03亿或</span><span>17.45</span><span>%，</span>占香港主板上市公司总市值309,855亿</span></span><span>的1.87%。</span></p>\n <p><span><strong><span>这63家按第18A章上市的未盈利生物科技公司</span></strong><span>(按本年涨幅从高到底排序)</span><strong><span>的股市表现：</span></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/f90093148eef4e948ac59921d1c98fa7\"></p>\n <p><img src=\"https://static.tigerbbs.com/2956d70fd0d94e1c91622c59924cabf6\"></p>\n <p><span><strong><span>一、2023年全年表现，涨</span></strong></span><span>(16)</span><span><strong><span>少</span></strong><strong><span>、跌</span></strong></span><span>(47)</span><span><strong><span>多</span></strong><strong></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/5d042843962249058415f6fa8101e53d\"></p>\n <p><span><span>2023年全年</span><span>上涨 <strong>16</strong></span><strong>家</strong><span>，平均涨幅 24.147%；下跌 </span><strong><span>47</span></strong><strong>家</strong><span>，</span><span>平均跌幅 42.937%。</span></span></p>\n <p><span><span>2023全年涨幅超过50%的3家，均为2023年当年上市，其中涨幅最大的是<strong>科伦博泰生物</strong></span><span><strong>-B</strong></span><span>(06990.HK)</span><span>，涨幅为69.80%，其后分别为<span><strong>宜明昂科</strong></span><span><strong>-B</strong></span><span>(01541.HK)</span></span></span><span>、</span><span><span><span><strong>来凯医药</strong></span><span><strong>-B</strong></span><span>(02105.HK)</span><span>，涨幅分别为60.75%、</span>60.36%。</span></span></p>\n <p><span><span><span><span>2023全</span><span>年</span><span>涨幅介于10%至50%的7家，涨幅不足10%的6家。</span></span></span></span></p>\n <p><span><span>2023全年跌幅超过50%的18家，其中跌幅最大的是<strong>开拓药业</strong></span><span><strong>-B</strong></span><span>(09939.HK)</span><span>，跌幅为83.45%，其次为</span></span><span><span><strong>3D Medicines</strong></span></span><span><span><span>(01244.HK)</span></span></span><span><span>，跌幅为82.02%。</span></span></p>\n <p><span><span>2023全年跌幅介于10%至50%的25家，跌幅在10%以内的4家。</span></span></p>\n <p><span><strong><span>二、上市以来累计表现</span></strong></span><span><strong><span>，涨</span></strong></span><span>(9)</span><span><strong><span>少</span></strong><strong><span>、跌</span></strong></span><span>(54)</span><span><strong><span>多</span></strong></span><span><strong><span></span></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/398a7d4a9313486b8c3ee5d02763d2d9\"></p>\n <p><span>这63家生物科技公司上市以来，</span><span>上涨 <strong>9</strong></span><strong>家</strong><span>，平均<span>累计</span>涨幅 62.28%；下跌 </span><strong><span><span>54</span></span><strong>家</strong></strong><span>，</span><span><span>平均</span><span>累计</span>跌幅 63.32%。</span></p>\n <p><span><span>累计涨幅有2家超过100%，其中累计涨幅最大的是<strong>信达生物</strong></span><span>(01801.HK)</span><span>，累计涨幅为205.79%，其次为</span></span><span><span><strong>康方生物</strong></span></span><span>(09926.HK)</span><span><span>，累计涨幅达186.77%。</span></span></p>\n <p><span><span>累计跌幅超过50%的高达40家，占全部未盈利生物科技公司数量的63.5%，其中跌幅超过90%的8家，跌幅80%~90%的11家。</span></span></p>\n <p><span><strong><span>三、上市市值</span></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/35a1f7cc2afc44b9a042eeaf7782203d\"></p>\n <p><img src=\"https://static.tigerbbs.com/9395ded9735b4a668233796053858155\"></p>\n <ul>\n <li><p><span>市值超过<strong>100亿美元</strong>的 <strong>1</strong><strong>家</strong>，占1.59%；</span></p></li>\n <li><p><span>市值介于<strong>10亿美元到100亿美元</strong>的 <strong>14</strong><strong>家</strong>，占22.22%；</span></p></li>\n <li><p><span>市值介于<strong>5亿美元到10亿美元</strong>的 <strong>14</strong><strong>家</strong>，占22.22%；</span></p></li>\n <li><p><span>市值介于<strong>1亿美元</strong>到<strong>5</strong><strong>亿美元</strong>的 <strong>28</strong><strong>家</strong>，占44.44%；</span></p></li>\n <li><p><span>市值不足<strong>1亿美元</strong>的 <strong>6</strong><strong>家</strong>，占9.52%</span><span>。</span></p></li>\n </ul>\n <p><span><span></span><span> * </span><span>美元</span><span>兑港股汇率以7.850</span><span>0计</span></span></p>\n <p><span><span>目前市值最高的是<strong>百济神州</strong></span><span>(06160.HK)</span><span>，市值为1490.87亿元</span></span><span>(189.92亿美元)</span><span>，占这3家总市值的25.77%；</span></p>\n <p><span><span>市值最低的是<strong>堃博医疗</strong><strong>-B</strong></span><span>(02216.HK)</span><span>，市值为4.16亿元<span>(0.53亿美元</span><span>)</span>。</span></span></p>\n <p><span>*本文由Ryanben Capital编辑，疏漏难免，敬请指正</span><span></span></p>\n</div></body></html>","htmlText":"<html><head></head><body><div>\n <p><span><img src=\"https://static.tigerbbs.com/ce841bc8a2f24d7abb80a7da31579c08\"></span></p>\n <p><span><span>截止至2023年12月31日，香港市场</span>共有<strong>63</strong>家未盈利生物科技公司在香港挂牌上市。</span><span><span>这<strong>63</strong>家全部在主板上市，从数量上来看，这<strong>63</strong>家占香港主板上市公司</span><strong><span>2,283</span></strong><span>家</span><span>的</span><span>2.76%；从市值上来看，这63家合计市值达<strong>5784.64</strong><strong>亿</strong>元<span>(港元，以下同)</span>，<span>较2022年12月31日未盈利生物科技公司总市值减少1388.03亿或</span><span>17.45</span><span>%，</span>占香港主板上市公司总市值309,855亿</span></span><span>的1.87%。</span></p>\n <p><span><strong><span>这63家按第18A章上市的未盈利生物科技公司</span></strong><span>(按本年涨幅从高到底排序)</span><strong><span>的股市表现：</span></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/f90093148eef4e948ac59921d1c98fa7\"></p>\n <p><img src=\"https://static.tigerbbs.com/2956d70fd0d94e1c91622c59924cabf6\"></p>\n <p><span><strong><span>一、2023年全年表现，涨</span></strong></span><span>(16)</span><span><strong><span>少</span></strong><strong><span>、跌</span></strong></span><span>(47)</span><span><strong><span>多</span></strong><strong></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/5d042843962249058415f6fa8101e53d\"></p>\n <p><span><span>2023年全年</span><span>上涨 <strong>16</strong></span><strong>家</strong><span>，平均涨幅 24.147%；下跌 </span><strong><span>47</span></strong><strong>家</strong><span>，</span><span>平均跌幅 42.937%。</span></span></p>\n <p><span><span>2023全年涨幅超过50%的3家，均为2023年当年上市，其中涨幅最大的是<strong>科伦博泰生物</strong></span><span><strong>-B</strong></span><span>(06990.HK)</span><span>，涨幅为69.80%，其后分别为<span><strong>宜明昂科</strong></span><span><strong>-B</strong></span><span>(01541.HK)</span></span></span><span>、</span><span><span><span><strong>来凯医药</strong></span><span><strong>-B</strong></span><span>(02105.HK)</span><span>，涨幅分别为60.75%、</span>60.36%。</span></span></p>\n <p><span><span><span><span>2023全</span><span>年</span><span>涨幅介于10%至50%的7家，涨幅不足10%的6家。</span></span></span></span></p>\n <p><span><span>2023全年跌幅超过50%的18家，其中跌幅最大的是<strong>开拓药业</strong></span><span><strong>-B</strong></span><span>(09939.HK)</span><span>，跌幅为83.45%，其次为</span></span><span><span><strong>3D Medicines</strong></span></span><span><span><span>(01244.HK)</span></span></span><span><span>，跌幅为82.02%。</span></span></p>\n <p><span><span>2023全年跌幅介于10%至50%的25家，跌幅在10%以内的4家。</span></span></p>\n <p><span><strong><span>二、上市以来累计表现</span></strong></span><span><strong><span>，涨</span></strong></span><span>(9)</span><span><strong><span>少</span></strong><strong><span>、跌</span></strong></span><span>(54)</span><span><strong><span>多</span></strong></span><span><strong><span></span></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/398a7d4a9313486b8c3ee5d02763d2d9\"></p>\n <p><span>这63家生物科技公司上市以来，</span><span>上涨 <strong>9</strong></span><strong>家</strong><span>，平均<span>累计</span>涨幅 62.28%；下跌 </span><strong><span><span>54</span></span><strong>家</strong></strong><span>，</span><span><span>平均</span><span>累计</span>跌幅 63.32%。</span></p>\n <p><span><span>累计涨幅有2家超过100%，其中累计涨幅最大的是<strong>信达生物</strong></span><span>(01801.HK)</span><span>，累计涨幅为205.79%，其次为</span></span><span><span><strong>康方生物</strong></span></span><span>(09926.HK)</span><span><span>，累计涨幅达186.77%。</span></span></p>\n <p><span><span>累计跌幅超过50%的高达40家，占全部未盈利生物科技公司数量的63.5%，其中跌幅超过90%的8家，跌幅80%~90%的11家。</span></span></p>\n <p><span><strong><span>三、上市市值</span></strong></span></p>\n <p><img src=\"https://static.tigerbbs.com/35a1f7cc2afc44b9a042eeaf7782203d\"></p>\n <p><img src=\"https://static.tigerbbs.com/9395ded9735b4a668233796053858155\"></p>\n <ul>\n <li><p><span>市值超过<strong>100亿美元</strong>的 <strong>1</strong><strong>家</strong>，占1.59%；</span></p></li>\n <li><p><span>市值介于<strong>10亿美元到100亿美元</strong>的 <strong>14</strong><strong>家</strong>，占22.22%；</span></p></li>\n <li><p><span>市值介于<strong>5亿美元到10亿美元</strong>的 <strong>14</strong><strong>家</strong>，占22.22%；</span></p></li>\n <li><p><span>市值介于<strong>1亿美元</strong>到<strong>5</strong><strong>亿美元</strong>的 <strong>28</strong><strong>家</strong>，占44.44%；</span></p></li>\n <li><p><span>市值不足<strong>1亿美元</strong>的 <strong>6</strong><strong>家</strong>，占9.52%</span><span>。</span></p></li>\n </ul>\n <p><span><span></span><span> * </span><span>美元</span><span>兑港股汇率以7.850</span><span>0计</span></span></p>\n <p><span><span>目前市值最高的是<strong>百济神州</strong></span><span>(06160.HK)</span><span>，市值为1490.87亿元</span></span><span>(189.92亿美元)</span><span>，占这3家总市值的25.77%；</span></p>\n <p><span><span>市值最低的是<strong>堃博医疗</strong><strong>-B</strong></span><span>(02216.HK)</span><span>，市值为4.16亿元<span>(0.53亿美元</span><span>)</span>。</span></span></p>\n <p><span>*本文由Ryanben Capital编辑，疏漏难免，敬请指正</span><span></span></p>\n</div></body></html>","text":"截止至2023年12月31日，香港市场共有63家未盈利生物科技公司在香港挂牌上市。这63家全部在主板上市，从数量上来看，这63家占香港主板上市公司2,283家的2.76%；从市值上来看，这63家合计市值达5784.64亿元(港元，以下同)，较2022年12月31日未盈利生物科技公司总市值减少1388.03亿或17.45%，占香港主板上市公司总市值309,855亿的1.87%。 这63家按第18A章上市的未盈利生物科技公司(按本年涨幅从高到底排序)的股市表现： 一、2023年全年表现，涨(16)少、跌(47)多 2023年全年上涨 16家，平均涨幅 24.147%；下跌 47家，平均跌幅 42.937%。 2023全年涨幅超过50%的3家，均为2023年当年上市，其中涨幅最大的是科伦博泰生物-B(06990.HK)，涨幅为69.80%，其后分别为宜明昂科-B(01541.HK)、来凯医药-B(02105.HK)，涨幅分别为60.75%、60.36%。 2023全年涨幅介于10%至50%的7家，涨幅不足10%的6家。 2023全年跌幅超过50%的18家，其中跌幅最大的是开拓药业-B(09939.HK)，跌幅为83.45%，其次为3D Medicines(01244.HK)，跌幅为82.02%。 2023全年跌幅介于10%至50%的25家，跌幅在10%以内的4家。 二、上市以来累计表现，涨(9)少、跌(54)多 这63家生物科技公司上市以来，上涨 9家，平均累计涨幅 62.28%；下跌 54家，平均累计跌幅 63.32%。 累计涨幅有2家超过100%，其中累计涨幅最大的是信达生物(01801.HK)，累计涨幅为205.79%，其次为康方生物(09926.HK)，累计涨幅达186.77%。 累计跌幅超过50%的高达40家，占全部未盈利生物科技公司数量的63.5%，其中跌幅超过90%的8家，跌幅80%~90%的11家。 三、上市市值 市值超过100亿美元的 1家，占1.59%； 市值介于10亿美元到100亿美元的 14家，占22.22%； 市值介于5亿美元到10亿美元的 14家，占22.22%； 市值介于1亿美元到5亿美元的 28家，占44.44%； 市值不足1亿美元的 6家，占9.52%。 * 美元兑港股汇率以7.8500计 目前市值最高的是百济神州(06160.HK)，市值为1490.87亿元(189.92亿美元)，占这3家总市值的25.77%； 市值最低的是堃博医疗-B(02216.HK)，市值为4.16亿元(0.53亿美元)。 *本文由Ryanben Capital编辑，疏漏难免，敬请指正","highlighted":1,"essential":1,"paper":2,"link":"https://laohu8.com/post/270870461894664","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["IE00B5MMRT66.SGD","LU1969619763.USD","01541","01244","09926","01801","02216","IE00B543WZ88.USD","LU0417516571.SGD","LU0307460666.USD","06990","LU0348784397.USD","LU0588546209.SGD","02105","09939","LU0348783233.USD","LU2328871848.SGD","LU1794554557.SGD","06160","LU1720050803.USD","BGNE","688235"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1610,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":2383,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":36,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/274642158862456"}
精彩评论